| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Periodontics/Prevention/Geriatrics (L.K.M., A.J.K., C.A.B.), University of Michigan, Ann Arbor, Michigan 48109-1078 and Department of Veterinary Biosciences (T.J.R.), The Ohio State University, Columbus, Ohio 43210
Address all correspondence and requests for reprints to: Laurie K. McCauley, Department of Periodontics/Prevention/Geriatrics, University of Michigan, 1011 North University Avenue, Ann Arbor, Michigan 48109-1078. E-mail: mccauley{at}umich.edu
PTH and PTH-related protein (PTHrP) bind to the PTH-1 (PTH/PTHrP)
receptor and produce anabolic and catabolic effects in bone. To
investigate postreceptor mechanisms of action, MC3T3-E1 cells were
induced to differentiate to optimize PTH-1 receptor expression, and
differentiated MC3T3-E1 cells were treated with varying doses of PTH
(134) for 1 h. Northern blot analysis revealed a dose-dependent
stimulation of steady state c-fos messenger RNA (mRNA),
with measurable expression at doses as low as 1 pM PTH. The
time course of c-fos mRNA induction was rapid, with peak
levels detected at 3045 min. Increased steady state
c-fos mRNA was due to increased transcription of the
c-fos gene as demonstrated by nuclear run-on assays and
was dependent on the temporal differentiation state of the MC3T3-E1
cells. Stimulation of c-fos mRNA was induced exclusively
by N-terminal PTH and PTHrP (which is also responsible for cAMP
activation), and did not occur with PTH (734), (5384), or PTHrP
(107139). The effects of PTH (134) on c-fos
stimulation were dependent on intracellular cAMP. Forskolin [a
guanine-nucleotide-binding protein (G
) agonist]
stimulated c-fos mRNA, whereas 9-(tetrahydro-2-furyl)
adenine (THFA) (a cAMP antagonist), 1,9 dideoxyforskolin (a cAMP
independent analog of forskolin), and phorbol 12-myristate 13-acetate
(a protein kinase C activator) did not. Furthermore, THFA inhibited the
ability of PTH (134) to stimulate c-fos mRNA in a
time-dependent manner. These findings indicate that
c-fos is transcriptionally regulated by PTH (134) in
osteoblastic cells, and that cAMP is a mediator of PTH-stimulated
c-fos induction. Several known bone-associated proteins
contain DNA binding sites in their promoter regions that recognize
c-fos in conjunction with c-jun (AP-1
sites). Consequently, the induction of c-fos by PTH
(134) in osteoblastic cells may be a sensitive indicator of PTH
effects in vitro and in vivo, and provide
valuable information regarding mechanisms of PTH action in bone.
This article has been cited by other articles:
![]() |
S. Yu, R. T. Franceschi, M. Luo, X. Zhang, D. Jiang, Y. Lai, Y. Jiang, J. Zhang, and G. Xiao Parathyroid Hormone Increases Activating Transcription Factor 4 Expression and Activity in Osteoblasts: Requirement for Osteocalcin Gene Expression Endocrinology, April 1, 2008; 149(4): 1960 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Koh, B. Demiralp, K. G. Neiva, J. Hooten, R. M. Nohutcu, H. Shim, N. S. Datta, R. S. Taichman, and L. K. McCauley Cells of the Osteoclast Lineage as Mediators of the Anabolic Actions of Parathyroid Hormone in Bone Endocrinology, November 1, 2005; 146(11): 4584 - 4596. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, J.-C. Dai, S. A. Orellana, and E. M. Greenfield Endogenous Protein Kinase Inhibitor {gamma} Terminates Immediate-early Gene Expression Induced by cAMP-dependent Protein Kinase (PKA) Signaling: TERMINATION DEPENDS ON PKA INACTIVATION RATHER THAN PKA EXPORT FROM THE NUCLEUS J. Biol. Chem., January 28, 2005; 280(4): 2700 - 2707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, A. J. Koh, N. S. Datta, J. Zhang, E. T. Keller, G. Xiao, R. T. Franceschi, N. J. D'Silva, and L. K. McCauley Impact of the Mitogen-activated Protein Kinase Pathway on Parathyroid Hormone-related Protein Actions in Osteoblasts J. Biol. Chem., July 9, 2004; 279(28): 29121 - 29129. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Betea, A. R. Bradwell, T. C. Harvey, G. P. Mead, H. Schmidt-Gayk, B. Ghaye, A. F. Daly, and A. Beckers Hormonal and Biochemical Normalization and Tumor Shrinkage Induced by Anti-Parathyroid Hormone Immunotherapy in a Patient with Metastatic Parathyroid Carcinoma J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3413 - 3420. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chattopadhyay, S. Yano, J. Tfelt-Hansen, P. Rooney, D. Kanuparthi, S. Bandyopadhyay, X. Ren, E. Terwilliger, and E. M. Brown Mitogenic Action of Calcium-Sensing Receptor on Rat Calvarial Osteoblasts Endocrinology, July 1, 2004; 145(7): 3451 - 3462. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sowa, H. Kaji, M. F. Iu, T. Tsukamoto, T. Sugimoto, and K. Chihara Parathyroid Hormone-Smad3 Axis Exerts Anti-apoptotic Action and Augments Anabolic Action of Transforming Growth Factor {beta} in Osteoblasts J. Biol. Chem., December 26, 2003; 278(52): 52240 - 52252. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Luparello, R. Sirchia, and D. Pupello PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression J. Cell Sci., June 15, 2003; 116(12): 2421 - 2430. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Demiralp, H.-L. Chen, A. J. Koh, E. T. Keller, and L. K. McCauley Anabolic Actions of Parathyroid Hormone during Bone Growth Are Dependent on c-fos Endocrinology, October 1, 2002; 143(10): 4038 - 4047. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Mccauley, A. J. Koh-Paige, H. Chen, C. Chen, C. Ontiveros, R. Irwin, and L. R. Mccabe Parathyroid Hormone Stimulates fra-2 Expression in Osteoblastic Cells in Vitro and in Vivo Endocrinology, May 1, 2001; 142(5): 1975 - 1981. [Abstract] [Full Text] |
||||
![]() |
D. Thomas, A Sunters, A Gentry, and A. Grigoriadis Inhibition of chondrocyte differentiation in vitro by constitutive and inducible overexpression of the c-fos proto-oncogene J. Cell Sci., January 2, 2000; 113(3): 439 - 450. [Abstract] [PDF] |
||||
![]() |
A. J. Koh, C. A. Beecher, T. J. Rosol, and L. K. McCauley 3',5'-Cyclic Adenosine Monophosphate Activation in Osteoblastic Cells: Effects on Parathyroid Hormone-1 Receptors and Osteoblastic Differentiation in Vitro Endocrinology, July 1, 1999; 140(7): 3154 - 3162. [Abstract] [Full Text] |
||||
![]() |
A. M. Ionescu, E. M. Schwarz, C. Vinson, J. E. Puzas, R. Rosier, P. R. Reynolds, and R. J. O'Keefe PTHrP Modulates Chondrocyte Differentiation through AP-1 and CREB Signaling J. Biol. Chem., April 6, 2001; 276(15): 11639 - 11647. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |